home / stock / trvi / trvi short
Short Information | Trevi Therapeutics Inc. (NYSE:TRVI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 19,886 |
Total Actual Volume | 209,881 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 994 |
Average Short Percentage | 6.53% |
Is there a TRVI Short Squeeze or Breakout about to happen?
See the TRVI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-11-2020 | $5.1466 | $5.22 | $5.22 | $5.0033 | 781 | 1 | 0.13% |
02-05-2020 | $4.89 | $5.38 | $5.38 | $4.89 | 1,204 | 1 | 0.08% |
02-03-2020 | $4.85 | $4.67 | $4.88 | $4.6298 | 2,545 | 1 | 0.04% |
01-31-2020 | $5.03 | $4.98 | $5.14 | $4.78 | 10,185 | 100 | 0.98% |
01-29-2020 | $5.08 | $5.34 | $5.37 | $4.7277 | 7,263 | 1,004 | 13.82% |
01-28-2020 | $5.14 | $5.14 | $5.14 | $5.14 | 360 | 1 | 0.28% |
01-27-2020 | $4.84 | $4.86 | $5.23 | $4.84 | 1,888 | 100 | 5.3% |
01-24-2020 | $5.18 | $5.18 | $5.18 | $4.7182 | 10,651 | 7 | 0.07% |
01-22-2020 | $5.0252 | $5.17 | $5.17 | $5.024 | 1,212 | 7 | 0.58% |
01-21-2020 | $5.10 | $5.20 | $5.23 | $5.0001 | 5,159 | 332 | 6.44% |
01-17-2020 | $5.37 | $5.33 | $5.3881 | $5.03 | 5,820 | 915 | 15.72% |
01-16-2020 | $5.0979 | $5.35 | $5.35 | $5.0979 | 3,283 | 1,113 | 33.9% |
01-15-2020 | $5.25 | $5.30 | $5.6731 | $4.7272 | 12,475 | 3 | 0.02% |
01-14-2020 | $5.40 | $5.01 | $5.6603 | $4.55 | 14,080 | 1,000 | 7.1% |
01-13-2020 | $5.35 | $5.20 | $5.6819 | $5.20 | 15,819 | 3,158 | 19.96% |
01-10-2020 | $5.25 | $5.23 | $5.37 | $5.00 | 10,406 | 1 | 0.01% |
01-09-2020 | $4.56 | $5.1697 | $5.1697 | $4.49 | 74,877 | 10,409 | 13.9% |
01-08-2020 | $4.48 | $4.41 | $4.5868 | $4.2396 | 6,350 | 322 | 5.07% |
01-07-2020 | $4.46 | $4.3759 | $4.60 | $4.30 | 4,579 | 30 | 0.66% |
01-06-2020 | $4.49 | $4.372 | $4.8858 | $4.0281 | 20,944 | 1,381 | 6.59% |
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NYSE Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference PR Newswire Professor Jacky Smith will present on the reduction of cough bouts with nalbuphine ER observed in patients with IPF in the CANAL trial NE...
Trevi Therapeutics to Participate in Upcoming April Events PR Newswire NEW HAVEN, Conn. , April 4, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio!...
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team PR Newswire Margaret Garin , MD, MSCR, joins team to advance the development of Haduvio in chronic cough indications NEW HAVEN, Conn. , April 2, 2024 /PRNewswir...